NASDAQ

Lakewood-Amedex Biotherapeutics Inc. (LABT)

♥ 552 Thanks from members

Live price chart, market sentiment, and community perspectives for Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Lakewood-Amedex Research TeamLeadership: Steven Burton (CEO)Holder: Private Equity and Venture InvestorsPolyMedica DerivativesBroad-Spectrum Antibiotics#LABT#Lakewood Amedex#biotech stock#NASDAQ LABT#anti-infective drugs